User profiles for I. M. MacDonald
Ian M MacDonaldEmeritus Professor, Ophthalmology and Visual Sciences, U Alberta Verified email at ualberta.ca Cited by 6477 |
Choroideremia: new findings from ocular pathology and review of recent literature
IM MacDonald, L Russell, CC Chan - Survey of ophthalmology, 2009 - Elsevier
… MacDonald MD, CM 1 , Laurie Russell MD 2 , Chi-Chao Chan MD 3 … The details of the
histology of this eye have been reported previously (IM MacDonald et al. Abstract No. 1034. …
histology of this eye have been reported previously (IM MacDonald et al. Abstract No. 1034. …
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy
…, LE Kakuk, PS Lagali, PW Wong, IM MacDonald… - Nature …, 2001 - nature.com
Stargardt-like macular dystrophy (STGD3, MIM 600110) and autosomal dominant macular
dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased …
dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased …
Choroideremia
IM MacDonald, N Binczyk, A Radziwon… - Hereditary Chorioretinal …, 2020 - Springer
Males affected by choroideremia (CHM) experience progressive choroidal and retinal
degeneration, which results in clinical symptoms of varying severity. The classical disease …
degeneration, which results in clinical symptoms of varying severity. The classical disease …
[HTML][HTML] RP1L1 and inherited photoreceptor disease: A review
NCL Noel, IM MacDonald - Survey of Ophthalmology, 2020 - Elsevier
Retinitis pigmentosa 1–like 1 (RP1L1) is a component of the photoreceptor cilium. Pathogenic
variants in RP1L1 lead to photoreceptor disease, suggesting an important role for RP1L1 …
variants in RP1L1 lead to photoreceptor disease, suggesting an important role for RP1L1 …
Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations
…, AJ Roman, EM Stone, IM MacDonald - … & visual science, 2006 - iovs.arvojournals.org
purpose. To characterize in detail the disease expression in choroideremia (CHM), a blinding
X-linked disease of the retina caused by loss-of-function mutations in Rab Escort Protein 1 …
X-linked disease of the retina caused by loss-of-function mutations in Rab Escort Protein 1 …
Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience
…, R Somani, MTS Tennant, IM MacDonald - American Journal of …, 2018 - Elsevier
Purpose To assess the safety of a recombinant adeno-associated viral vector expressing
REP1 (rAAV2.REP1) in choroideremia subjects. Methods Design: Phase I clinical trial. …
REP1 (rAAV2.REP1) in choroideremia subjects. Methods Design: Phase I clinical trial. …
The 87Sr86Sr values of Canadian Shield brines and fracture minerals with applications to groundwater mixing, fracture history, and geochronology
Analyses of saline waters, fracture minerals, and host rocks from seven localities on the
Canadian Shield demonstrate the utility of the 87 Sr 86 Sr ratio in the study of groundwater …
Canadian Shield demonstrate the utility of the 87 Sr 86 Sr ratio in the study of groundwater …
Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics
…, B Kousal, TM Lamey, IM MacDonald… - Genetics in …, 2020 - nature.com
Purpose Missing heritability in human diseases represents a major challenge, and this is
particularly true for ABCA4-associated Stargardt disease (STGD1). We aimed to elucidate the …
particularly true for ABCA4-associated Stargardt disease (STGD1). We aimed to elucidate the …
Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness
…, S Cao, S Fahiminiya, H Ren, IM MacDonald… - Nature …, 2015 - nature.com
Blindness due to retinal degeneration affects millions of people worldwide, but many
disease-causing mutations remain unknown. PNPLA6 encodes the patatin-like phospholipase …
disease-causing mutations remain unknown. PNPLA6 encodes the patatin-like phospholipase …
Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders
BJ Marriage, MT Clandinin, IM Macdonald… - Molecular genetics and …, 2004 - Elsevier
Marked progress has been made over the past 15 years in defining the specific biochemical
defects and underlying molecular mechanisms of oxidative phosphorylation disorders, but …
defects and underlying molecular mechanisms of oxidative phosphorylation disorders, but …